In Brief: Grace reviewing NMC options
This article was originally published in The Gray Sheet
Grace reviewing NMC options: W.R. Grace's newly elected president and CEO Albert Costello tells shareholders at Grace's May 10 annual meeting that the firm is weighing several alternatives for the divestiture of its National Medical Care dialysis unit. Last week, Grace received a $3.5 bil. acquisition offer for NMC from Constantine Hampers, a Grace executive VP and NMC's chairman and CEO ("The Gray Sheet" May 8, p. 14). "We are giving [Hampers'] proposal serious consideration and have retained the services of Merrill Lynch and First Boston to help us evaluate it," Costello told the stockholders in Boca Raton, Florida. Grace's board will "evaluate the Hampers proposal and other alternatives relating to NMC within approximately 30 to 60 days," the company said in a release...
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.